Kirby-Bauer Disk Diffusion Test: Protocol and Interpretation for Clinical Microbiology

The Kirby-Bauer disk diffusion test, also known as the disk diffusion method, is a standardized laboratory procedure used to determine the susceptibility of bacterial isolates to antimicrobial agents. This method involves placing paper disks impregnated with specific concentrations of antibiotics onto an agar plate inoculated with a standardized bacterial suspension. After incubation, the diameter of the zone of inhibition around each disk is measured and compared against established interpretive criteria to classify the isolate as susceptible, intermediate, or resistant. This article provides a detailed protocol for performing the Kirby-Bauer method, including inoculum preparation, disk placement, incubation conditions, and interpretation of results, with attention to quality control, common errors, and clinical reporting practices.

The Kirby-Bauer disk diffusion test is one of the most widely used antimicrobial susceptibility testing methods in clinical microbiology laboratories worldwide. It is employed for routine testing of rapidly growing bacteria such as Enterobacterales, staphylococci, and Pseudomonas aeruginosa. The method is valued for its simplicity, cost-effectiveness, and reproducibility when performed according to standardized protocols. The Clinical and Laboratory Standards Institute (CLSI) publishes regularly updated guidelines that define the technical parameters and interpretive criteria for disk diffusion testing. Adherence to current CLSI breakpoints is essential because outdated interpretive criteria can lead to misclassification of susceptibility results, potentially compromising patient treatment decisions.

At a Glance

The Kirby-Bauer disk diffusion test follows a defined sequence of steps, each with specific quality requirements. The table below summarizes the critical parameters for performing and interpreting the test.

Scientific Principles of Disk Diffusion Testing

The disk diffusion method relies on the diffusion of an antimicrobial agent from a paper disk into the surrounding agar medium. As the antibiotic diffuses outward, a concentration gradient forms, with the highest concentration near the disk and decreasing concentrations at increasing distances. Bacterial growth on the agar surface is inhibited where the antibiotic concentration exceeds the minimum inhibitory concentration (MIC) for that organism. The resulting zone of inhibition reflects the susceptibility of the organism to the antibiotic under the standardized test conditions.

Several factors influence the size of the zone of inhibition. The molecular weight and solubility of the antimicrobial agent affect its rate of diffusion through the agar. The density and growth rate of the test organism influence how quickly the organism spreads across the plate relative to the diffusion of the antibiotic. The composition and depth of the agar medium affect both diffusion characteristics and bacterial growth. The pH of the medium can alter the activity of certain antibiotics, which is why Mueller-Hinton agar is specifically formulated and quality controlled for this purpose.

The relationship between zone diameter and MIC is not linear but follows a predictable pattern for each antibiotic-organism combination. CLSI establishes interpretive breakpoints based on large datasets correlating zone diameters with MIC values and clinical outcomes. These breakpoints are periodically revised as new resistance mechanisms emerge and clinical data accumulate. A retrospective analytical study examining the impact of outdated CLSI breakpoints on susceptibility interpretation found that using previous breakpoints led to significant misclassification of isolates, particularly for aminoglycosides against Enterobacterales and for linezolid against Staphylococcus aureus. The study analyzed 9,279 bacterial isolates and demonstrated that updated breakpoints reclassified many isolates from susceptible to intermediate categories, highlighting the importance of implementing current standards in routine laboratory practice.

Required Materials and Equipment

Culture Media

Mueller-Hinton agar is the standard medium for disk diffusion testing of non-fastidious bacteria. The medium must be prepared according to the manufacturer's instructions and poured into Petri plates to a uniform depth of 4 mm. Plates should be stored at 2 to 8°C and used within a specified period, typically one to two weeks, to prevent drying and changes in pH. Before use, plates should be checked for surface moisture, and excess moisture should be allowed to evaporate with the lids slightly ajar in a laminar flow hood or biosafety cabinet.

For fastidious organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria gonorrhoeae, supplemented media are required. Mueller-Hinton agar with 5% defibrinated sheep blood is used for streptococci, while Haemophilus test medium is used for H. influenzae. These specialized media support the growth of fastidious organisms while maintaining the standardized conditions necessary for reliable zone diameter interpretation.

Antimicrobial Disks

Antimicrobial disks are commercially prepared paper disks impregnated with defined concentrations of antibiotics. The disks must be stored according to manufacturer recommendations, typically in sealed containers with desiccant at 2 to 8°C or frozen for long-term storage. Disks should be allowed to reach room temperature before opening containers to prevent condensation and moisture accumulation, which can degrade the antimicrobial agents. Expired disks must never be used, as reduced antibiotic potency can produce falsely large zones of inhibition.

McFarland Standard

The McFarland turbidity standard is used to standardize the bacterial inoculum density. A 0.5 McFarland standard corresponds to approximately 1.5 × 10^8 colony-forming units per milliliter for most bacteria. Commercially prepared McFarland standards are available, or the standard can be prepared in the laboratory using barium sulfate or other approved methods. The standard should be verified periodically and stored in the dark to prevent degradation.

Inoculation and Measurement Equipment

Sterile cotton swabs, a sterile inoculating loop or needle, forceps or a disk dispenser, and a ruler or calipers for measuring zone diameters are required. A McFarland turbidity meter or densitometer can be used for more precise inoculum standardization. Quality control organisms with known susceptibility patterns are essential for validating each batch of media and disks.

Inoculum Preparation

Isolate Selection and Purity

The Kirby-Bauer test begins with a pure culture of the organism to be tested. The isolate should be obtained from a primary culture plate and examined for purity. Mixed cultures produce unreliable results because different organisms may have different susceptibility patterns, and the zone of inhibition may reflect the most resistant population instead of the clinically relevant organism. Subculture the isolate to a fresh agar plate to obtain isolated colonies before preparing the inoculum.

Suspension Preparation

Using a sterile loop or swab, select three to five well-isolated colonies of the same morphological type from the culture plate. Transfer the colonies to a tube containing 3 to 5 mL of sterile saline or Mueller-Hinton broth. Vortex the tube thoroughly to create a uniform suspension. The turbidity of the suspension should be adjusted to match the 0.5 McFarland standard. This can be done visually against a white background with contrasting black lines or using a turbidity meter for greater precision.

The inoculum density is critical because it directly affects the zone diameter. An overly dense inoculum produces smaller zones of inhibition, potentially leading to false resistance results. An overly dilute inoculum produces larger zones, potentially leading to false susceptibility results. The 0.5 McFarland standard provides a reproducible starting point that has been validated for most clinically significant bacteria.

Timing of Inoculum Use

The standardized suspension should be used within 15 to 30 minutes of preparation. Bacteria in suspension can multiply or die during extended storage, altering the effective inoculum density. If a delay occurs, the suspension should be restandardized or freshly prepared. The suspension should be prepared from an actively growing culture, typically an 18 to 24 hour plate culture, to ensure the organisms are in the logarithmic phase of growth.

Inoculation of the Agar Plate

Swab Inoculation Technique

A sterile cotton swab is dipped into the standardized bacterial suspension. Excess liquid is removed by pressing and rotating the swab against the inside of the tube above the fluid level. The swab is then streaked across the entire surface of the Mueller-Hinton agar plate in three directions, rotating the plate approximately 60 degrees between each streaking. This three-directional streaking ensures even distribution of the inoculum and produces confluent growth after incubation.

After the third streaking direction, the swab may be streaked around the rim of the plate to ensure complete coverage. The plate should be allowed to dry for 3 to 5 minutes with the lid slightly ajar to allow excess surface moisture to absorb into the agar. If the plate is not sufficiently dry, the antimicrobial disks may float or move, and the zones of inhibition may be irregular.

Verification of Inoculum Density

Some laboratories perform a colony count on the inoculum suspension to verify that it contains the expected bacterial concentration. This involves diluting the suspension and plating a measured volume onto agar, then counting colonies after incubation. While this verification step is not required for routine testing, it is valuable for troubleshooting inconsistent results and for validating new technicians or new lots of McFarland standards.

Disk Placement

Disk Dispensing

Antimicrobial disks are placed onto the inoculated agar surface using sterile forceps or a disk dispenser. The disks should be gently pressed onto the agar surface to ensure complete contact. Once placed, disks should not be moved, as this can disrupt the diffusion gradient and produce irregular zones. A maximum of 12 disks should be placed on a 150 mm plate, and 5 to 6 disks on a 100 mm plate. The disks should be arranged so that the zones of inhibition do not overlap, which requires a minimum distance of 24 mm between disk centers.

Disk Selection

The selection of antimicrobial disks should be guided by the organism being tested, the clinical context, and the laboratory's reporting policies. Laboratories typically test a panel of antibiotics relevant to the organism group and the local formulary. For example, Enterobacterales are commonly tested against ampicillin, cephalosporins, aminoglycosides, fluoroquinolones, and trimethoprim-sulfamethoxazole. The specific panel should be reviewed regularly to ensure it reflects current treatment guidelines and local resistance patterns.

Disk Storage and Handling

Disks should be removed from the refrigerator or freezer and allowed to equilibrate to room temperature before the container is opened. Opening a cold container allows warm, moist air to enter, causing condensation that can degrade the antibiotics. The disk container should be closed immediately after removing the required disks to minimize exposure to humidity. Disks should be used before the expiration date printed on the container, and any disks showing discoloration or other signs of deterioration should be discarded.

Incubation Conditions

Temperature and Duration

Inoculated plates are incubated at 35 ± 2°C for 16 to 24 hours in ambient air. The incubation temperature and duration are standardized because both affect bacterial growth rate and antibiotic diffusion. Extended incubation can allow resistant subpopulations to grow within the zone of inhibition, producing false resistance results. Conversely, insufficient incubation may produce zones that are too large because the organism has not yet grown to the expected density.

Special Incubation Requirements

Some organisms require modified incubation conditions. For example, streptococci are incubated in 5% carbon dioxide, and Haemophilus species require specific atmospheric conditions and supplemented media. These modifications are specified in the CLSI guidelines for each organism group. Laboratories must follow the appropriate protocol for the organism being tested to ensure valid results.

Reading the Plates

After incubation, the plates are examined for confluent growth. The lawn of growth should be uniform across the plate, with no isolated colonies or skipped areas. If the growth is not confluent, the test should be repeated. The zone of inhibition is measured as the diameter of the area with no visible growth, measured to the nearest millimeter. The measurement is taken across the center of the disk, and the endpoint is read at the point of obvious inhibition as judged by the naked eye.

For organisms that swarm, such as Proteus species, the zone edge may be obscured by swarming growth. In such cases, the zone is measured at the point where the swarming growth begins. For organisms that produce faint growth within the zone, such as some enterococci, the zone edge is read at the point of significant reduction in growth instead of complete absence of growth.

Interpretation of Results

Interpretive Categories

Zone diameters are compared to the interpretive breakpoints published in the current CLSI tables. Results are reported as susceptible, intermediate, or resistant. A susceptible result indicates that the organism is likely to respond to treatment with the antibiotic at the standard dosing regimen. An intermediate result indicates that the organism may respond to treatment if the antibiotic is used at a higher dose or if the infection is at a body site where the antibiotic concentrates. A resistant result indicates that the organism is unlikely to respond to treatment with that antibiotic.

The intermediate category also serves as a buffer zone that accounts for technical variation in the test. Isolates falling into the intermediate category may be tested by an alternative method, such as broth microdilution, to determine the exact MIC. This information can guide dose adjustment or alternative antibiotic selection.

Importance of Current Breakpoints

The use of current CLSI breakpoints is essential for accurate interpretation. A retrospective analytical study of 9,279 bacterial isolates demonstrated that outdated breakpoints significantly overestimated susceptibility for several antibiotic-organism combinations. For Enterobacterales, analysis of 2,262 aminoglycoside zone diameters revealed significant misclassification when outdated breakpoints were applied. Gentamicin showed a significant shift in susceptibility distribution, with paired analysis confirming correction of susceptible isolates to the intermediate category using updated breakpoints. Amikacin demonstrated substantial paired misclassification despite a borderline overall shift. For Pseudomonas aeruginosa, piperacillin-tazobactam and tobramycin showed significant redistribution of susceptibility categories, with older criteria overestimating susceptibility. For Staphylococcus aureus, implementation of revised linezolid breakpoints introduced an intermediate category and resulted in significant reclassification from susceptible to intermediate.

These findings underscore the clinical importance of updating laboratory protocols whenever CLSI publishes revised breakpoints. Laboratories should have a system for tracking CLSI updates and implementing changes in a timely manner. This includes updating interpretive tables, retraining staff, and notifying clinicians of any changes that may affect the interpretation of previously reported results.

Reporting Results

Susceptibility results should be reported to clinicians in a clear and actionable format. The report should include the organism identification, the antibiotics tested, and the interpretive category for each antibiotic. Some laboratories also report the zone diameter and the MIC when available. The report should indicate the testing method and the breakpoint version used, particularly when results may be compared across time or between laboratories.

Laboratories should have policies for reporting results that are consistent with local treatment guidelines and antimicrobial stewardship programs. For example, some laboratories report only the antibiotics that are relevant to the clinical context, while others report a standard panel. The laboratory should also have a mechanism for flagging unusual or unexpected resistance patterns that may indicate contamination, mixed cultures, or emerging resistance mechanisms.

Quality Control

Control Organisms

Quality control is an essential component of the Kirby-Bauer disk diffusion test. Control organisms with known susceptibility patterns are tested alongside clinical isolates to validate the performance of the media, disks, and testing procedure. The choice of control organisms depends on the organism group being tested. Common control strains include Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 27853, and Enterococcus faecalis ATCC 29212.

Control organisms should be tested at least weekly, and whenever a new lot of media or disks is introduced. The zone diameters for control organisms must fall within the acceptable ranges published by CLSI. If a control result falls outside the acceptable range, the test is invalid, and corrective action is required before clinical results can be reported.

Corrective Action

When a quality control failure occurs, the laboratory must investigate the cause before repeating the test. Possible causes include contaminated media, expired or degraded disks, incorrect inoculum density, improper incubation conditions, or errors in measurement. The investigation should include checking the expiration dates of media and disks, verifying the McFarland standard, and reviewing the testing procedure. The corrective action should be documented, and the test should be repeated with fresh materials.

Documentation

Quality control results should be documented in a log that includes the date, the control organism, the antibiotic disks tested, the zone diameters obtained, and the acceptable ranges. The log should also document any corrective actions taken in response to out-of-range results. This documentation is necessary for laboratory accreditation and provides a record of the laboratory's testing quality over time.

Common Failure Patterns and Troubleshooting

Zone Diameters Too Large or Too Small

Zone diameters that are consistently larger than expected may indicate an inoculum that is too dilute, agar that is too thick, or disks with excessive antibiotic potency. Zone diameters that are consistently smaller than expected may indicate an inoculum that is too dense, agar that is too thin, or degraded disks. The first step in troubleshooting is to verify the inoculum density against the McFarland standard and to check the agar depth.

Irregular or Indistinct Zone Edges

Irregular zone edges can result from uneven inoculation, insufficient drying of the agar surface, or movement of the disks after placement. Indistinct zone edges can occur with organisms that produce faint growth, such as enterococci, or with antibiotics that diffuse slowly. Reading the zone at the point of significant growth reduction instead of complete inhibition can help standardize measurements for these organisms.

No Zone of Inhibition

A complete absence of a zone of inhibition may indicate that the organism is resistant to the antibiotic, that the disk was not placed on the agar surface, or that the disk is expired or degraded. The test should be repeated with a fresh disk to rule out disk failure. If the organism is known to be susceptible to the antibiotic based on previous testing, the quality control results should be reviewed to ensure the test system is functioning properly.

Contamination

Contamination of the culture or the agar plate can produce misleading results. The purity of the isolate should be confirmed before testing, and the inoculated plate should be examined for colonies with different morphologies after incubation. If contamination is suspected, the test should be repeated from a fresh pure culture.

Applications in Clinical and Research Settings

Clinical Diagnostic Use

The Kirby-Bauer disk diffusion method is widely used in clinical microbiology laboratories for routine susceptibility testing of bacterial isolates from clinical specimens. The method is particularly useful for laboratories with limited resources because it requires minimal equipment and is relatively inexpensive compared to automated susceptibility testing systems. Studies have demonstrated that disk diffusion results correlate well with reference methods for many organism-antibiotic combinations.

A study evaluating three direct susceptibility testing protocols for Gram-negative rods from flagged positive blood culture bottles found that the Kirby-Bauer disk diffusion method performed with standard inoculum prepared from bacterial pellets showed categorical agreement of 95.9% with the reference method. The study included both Enterobacterales and non-fermenters and found that the performance of the disk diffusion method was not statistically different between these organism groups. These findings support the use of disk diffusion for direct susceptibility testing from positive blood cultures, which can facilitate earlier administration of effective antimicrobial therapy.

Surveillance and Research Use

The Kirby-Bauer method is also used in antimicrobial resistance surveillance programs and research studies. National surveillance programs, such as the invasive group A streptococcal disease surveillance in Canada, use Kirby-Bauer disk diffusion according to CLSI guidelines to determine antimicrobial susceptibilities of collected isolates. Surveillance data inform public health policy and track the emergence and spread of resistant organisms.

Research studies use the Kirby-Bauer method to characterize the resistance profiles of clinical and environmental isolates. For example, a study of neonatal urinary tract infections used the Kirby-Bauer disk diffusion method and the VITEK 2 Compact system to determine antimicrobial resistance profiles of causative organisms. The study found that 75% of Escherichia coli strains demonstrated resistance to ampicillin and that multidrug resistance was present in 55% of E. coli, 100% of Enterobacter species, 38.5% of Klebsiella pneumoniae, and 20% of Enterococcus species. These findings highlight the serious problem of antimicrobial resistance in neonatal infections and the limited treatment options for multidrug-resistant organisms.

A study of Candida albicans isolates from vulvovaginal candidiasis cases used the Kirby-Bauer disk diffusion method to determine antifungal susceptibility. The study found that nystatin showed the highest sensitivity at 60%, followed by miconazole at 54.29% and fluconazole at 42.86%. Ketoconazole and voriconazole exhibited the highest resistance rates at 60%, while itraconazole and clotrimazole showed resistance rates of 51.43% and 48.57%, respectively. These findings demonstrate the utility of disk diffusion for antifungal susceptibility testing and the growing challenge of antifungal resistance.

Veterinary and Environmental Applications

The Kirby-Bauer method is also applied in veterinary microbiology and environmental monitoring. A study of Enterobacter species from poultry droppings in southwest Nigeria used the Kirby-Bauer disk diffusion method to test isolates against 20 antibiotics. All isolates were resistant to amoxicillin, cefpodoxime, and cefixime, with high resistance to cefotaxime at 98.6%, ceftriaxone at 86.1%, and cefuroxime at 84.7%. All Enterobacter species were multiple antibiotic-resistant, and 52.8% harbored at least one antibiotic resistance gene. This study demonstrated that multidrug-resistant Enterobacter species are present in poultry droppings and may pose a health threat to humans and animals.

A study of Escherichia coli from an integrated agroforestry-livestock system in Indonesia used the Kirby-Bauer disk diffusion protocol to assess antimicrobial resistance. The study found that ampicillin and tetracyclines exhibited high resistance levels among the studied animal species, and that a relatively lower multidrug resistance for E. coli was associated with grazing on pasture. These findings provide baseline epidemiological information for understanding the drivers and patterns of antimicrobial resistance in agricultural systems.

Limitations of the Kirby-Bauer Method

Organism and Antibiotic Limitations

The Kirby-Bauer disk diffusion method is not suitable for all organisms or all antibiotics. Slow-growing organisms, fastidious organisms, and anaerobes require specialized testing methods. Some antibiotics diffuse poorly through agar and cannot be reliably tested by disk diffusion. For these situations, broth microdilution or agar dilution methods are preferred.

The method provides a qualitative or semi-quantitative result instead of an exact MIC. For clinical decisions requiring precise MIC values, such as adjusting doses for infections caused by organisms with borderline susceptibility, broth microdilution or gradient diffusion methods may be necessary.

Breakpoint Limitations

Interpretive breakpoints are established for specific organism-antibiotic combinations and may not be available for all combinations. A study of nitroxoline activity against multidrug-resistant Escherichia coli and Klebsiella pneumoniae noted that interpretation of findings for K. pneumoniae was constrained by the lack of established clinical breakpoints. When breakpoints are not available, the laboratory cannot provide a definitive susceptibility interpretation, and the clinician must use other information to guide treatment decisions.

Technical Variability

The Kirby-Bauer method is subject to technical variability that can affect the accuracy and reproducibility of results. Variations in inoculum density, agar depth, incubation conditions, and measurement technique can all influence zone diameters. Strict adherence to standardized protocols and regular quality control testing are essential to minimize this variability.

Biosafety and Laboratory Safety Considerations

Handling of Clinical Isolates

The Kirby-Bauer disk diffusion test involves handling viable bacterial cultures, which may include pathogenic organisms. All work should be performed in a biosafety cabinet using appropriate personal protective equipment, including gloves and a laboratory coat. The World Health Organization Laboratory Biosafety Manual provides guidance on the safe handling of infectious microorganisms and the appropriate biosafety levels for different organisms.

Laboratories should have written procedures for the safe handling of cultures, including decontamination of work surfaces, proper disposal of contaminated materials, and management of spills. Personnel should receive training in biosafety practices and should be aware of the risks associated with the organisms they handle.

Waste Disposal

Contaminated materials, including inoculated plates, swabs, and pipettes, should be disposed of according to laboratory waste management protocols. This typically involves autoclaving or chemical disinfection before disposal. The World Health Organization Laboratory Quality Management System Handbook provides guidance on waste management practices for clinical laboratories.

Quality Management

The Kirby-Bauer disk diffusion test should be performed within a quality management system that includes documented procedures, training and competency assessment of personnel, internal quality control, and participation in external quality assessment or proficiency testing programs. The World Health Organization Laboratory Quality Management System Handbook describes the components of a quality management system for clinical laboratories and provides guidance for implementation.

Records and Documentation

Test Records

Each Kirby-Bauer test should be documented with the following information: patient or sample identifier, organism identification, date of testing, antibiotics tested, zone diameters measured, interpretive categories, and the breakpoint version used. The records should also include the technician who performed the test and any quality control results associated with the test run.

Quality Control Records

Quality control records should include the dates of testing, the control organisms used, the zone diameters obtained for each antibiotic, and the acceptable ranges. Any out-of-range results and the corrective actions taken should be documented. These records provide evidence of the laboratory's testing quality and are reviewed during accreditation inspections.

Maintenance of Records

Test records and quality control records should be retained for a defined period, typically several years, according to laboratory policy and regulatory requirements. The records should be stored in a manner that ensures confidentiality and allows retrieval when needed for audit or review.

Professional Escalation Criteria

When to Repeat Testing

The test should be repeated when quality control results are out of range, when the growth on the plate is not confluent, when contamination is suspected, or when the results are inconsistent with the organism's expected susceptibility pattern. Repeated testing with fresh materials and careful attention to the protocol can resolve many technical issues.

When to Use Alternative Methods

Alternative susceptibility testing methods, such as broth microdilution or gradient diffusion, should be used when the organism is not suitable for disk diffusion, when precise MIC values are needed for clinical decisions, or when disk diffusion results are equivocal. The laboratory should have protocols for selecting and performing alternative methods.

When to Notify Clinicians

The laboratory should notify clinicians promptly when susceptibility results indicate resistance to first-line antibiotics, when unusual or unexpected resistance patterns are detected, or when there is a delay in reporting results. Timely communication of susceptibility results is critical for guiding antimicrobial therapy, particularly for seriously ill patients.

When to Escalate to Public Health Authorities

Certain resistance patterns, such as carbapenem resistance in Enterobacterales or vancomycin resistance in Staphylococcus aureus, may require notification of public health authorities. A study of carbapenem-resistant Acinetobacter baumannii in Nepal found a high prevalence of the blaOXA-23 gene among isolates, with 97% sensitive to colistin but only 12.1% sensitive to meropenem and imipenem. The study recommended systematic network surveillance to check the spread of such isolates, especially in intensive care units. Laboratories should be aware of local reporting requirements and have protocols for notifying public health authorities of notifiable resistance patterns.

Frequently Asked Questions

What is the difference between the Kirby-Bauer disk diffusion method and broth microdilution?

The Kirby-Bauer disk diffusion method measures the zone of inhibition around an antibiotic disk on an agar plate and classifies the organism as susceptible, intermediate, or resistant based on the zone diameter. Broth microdilution determines the minimum inhibitory concentration (MIC), which is the lowest concentration of antibiotic that inhibits visible growth of the organism. The MIC provides a quantitative result that can guide dose selection, while disk diffusion provides a qualitative or semi-quantitative result. Both methods are standardized by CLSI, and the choice of method depends on the organism, the clinical context, and laboratory resources.

How is the 0.5 McFarland standard prepared?

The 0.5 McFarland standard can be prepared by adding 0.5 mL of 1.175% barium chloride dihydrate to 99.5 mL of 1% sulfuric acid. The solution is mixed and dispensed into tubes that match the tubes used for inoculum preparation. The turbidity of the standard should be verified periodically using a spectrophotometer or turbidity meter. Commercially prepared standards are also available and are preferred by many laboratories for convenience and consistency.

Why is Mueller-Hinton agar used for the Kirby-Bauer test?

Mueller-Hinton agar is used because it supports the growth of most non-fastidious bacteria, has a defined pH that is optimal for antibiotic activity, and provides consistent diffusion characteristics for antimicrobial agents. The agar is low in sulfonamide, trimethoprim, and tetracycline antagonists, which could interfere with the activity of these antibiotics. The medium is quality controlled by manufacturers to ensure batch-to-batch consistency.

How many disks can be placed on a single plate?

A maximum of 12 disks should be placed on a 150 mm plate, and 5 to 6 disks on a 100 mm plate. The disks should be arranged so that the zones of inhibition do not overlap, which requires a minimum distance of 24 mm between disk centers. Placing too many disks on a plate can cause overlapping zones, making it difficult to measure zone diameters accurately.

What does an intermediate result mean?

An intermediate result indicates that the organism may respond to treatment if the antibiotic is used at a higher dose or if the infection is at a body site where the antibiotic concentrates. The intermediate category also serves as a buffer zone that accounts for technical variation in the test. Isolates falling into the intermediate category may be tested by an alternative method to determine the exact MIC, which can guide dose adjustment or alternative antibiotic selection.

How often should quality control testing be performed?

Quality control testing should be performed at least weekly, and whenever a new lot of media or disks is introduced. Control organisms with known susceptibility patterns are tested alongside clinical isolates to validate the performance of the test system. If a control result falls outside the acceptable range, the test is invalid, and corrective action is required before clinical results can be reported.

Why is it important to use current CLSI breakpoints?

Current CLSI breakpoints reflect the most up-to-date understanding of the relationship between zone diameters, MIC values, and clinical outcomes. Outdated breakpoints can overestimate susceptibility, leading to ineffective treatment. A study of 9,279 bacterial isolates found that outdated breakpoints significantly misclassified isolates for several antibiotic-organism combinations, including aminoglycosides against Enterobacterales and linezolid against Staphylococcus aureus. Laboratories should track CLSI updates and implement changes in a timely manner.

Can the Kirby-Bauer method be used for antifungal susceptibility testing?

The Kirby-Bauer disk diffusion method can be used for antifungal susceptibility testing of yeast, including Candida species. CLSI has published guidelines for disk diffusion testing of antifungal agents. A study of Candida albicans isolates from vulvovaginal candidiasis cases used the Kirby-Bauer disk diffusion method and found that nystatin showed the highest sensitivity at 60%, followed by miconazole at 54.29% and fluconazole at 42.86%. The method is useful for routine testing and surveillance, although broth microdilution remains the reference method for antifungal susceptibility testing.

Related Diagnostic Guides

• How to Perform a Kirby-Bauer Disk Diffusion Susceptibility Test: Protocol and Interpretation
• How to Perform a Kirby-Bauer Disk Diffusion Test: Protocol and Quality Control
• How to Calculate the Number of Bacteria Using the Kirby-Bauer Disk Diffusion Method
• Disk Diffusion Method for Antimicrobial Susceptibility Testing: Protocol and Interpretation
• How to Interpret Kirby-Bauer Disk Diffusion Results Using CLSI Breakpoints

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• The rising threat of antibiotic and multidrug resistance in neonatal urinary tract infections.. BMC pediatrics, 2025.
• Genetic diversity and antifungal resistance in Candida albicans from VVC cases in Indian women.. BMC microbiology, 2025.
• Detection of blaoxa-23 Gene from Carbapenem-resistant Acinetobacter Baumannii.. Journal of Nepal Health Research Council, 2023.
• Evaluation of three protocols for direct susceptibility testing for Gram-negative rods from flagged positive blood culture bottles.. Microbiology spectrum, 2024.
• Correlation between the antibiotic resistance and virulence determinants of vancomycin-resistant enterococci: paradoxical involvement of vanA in phenotypic resistance to teicoplanin.. Gut pathogens, 2025.
• Invasive group A streptococcal disease surveillance in Canada, 2021-2022.. Canada communicable disease report = Releve des maladies transmissibles au Canada, 2024.
• Invasive group A streptococcal disease surveillance in Canada, 2020.. Canada communicable disease report = Releve des maladies transmissibles au Canada, 2022.
• The effect of different solutions in tracheal suctioning on the incidence of pneumonia in patients on the ventilator.. Cellular and molecular biology (Noisy-le-Grand, France), 2022.
• Contrasting In Vitro Activity of Nitroxoline Against Multidrug-Resistant &lt,i&gt,Escherichia coli&lt,/i&gt, and &lt,i&gt,Klebsiella pneumoniae&lt,/i&gt, Isolates from Outpatients.. 2026.
• Evaluation of Beta-Lactamase-Producing Strains Isolated in a Tertiary Nephrology Hospital in Romania. 2026.
• Prevalence of Moraxella Species Among Lower Respiratory Tract Infections in and Around Kanchipuram.. 2026.
• Impact of Outdated Clinical and Laboratory Standards Institute (CLSI) Breakpoint Implementation on Antimicrobial Susceptibility Interpretation: A Retrospective Analytical Study.. 2026.
• In Vitro Activity of Cefiderocol, Eravacycline, and Imipenem-Relebactam Against Multidrug-Resistant &lt,i&gt,Acinetobacter baumannii&lt,/i&gt, Clinical Isolates.. 2026.
• Kirby-Bauer Disk Diffusion Susceptibility Test Protocol. 2009.
• Bacterial profile, treatment outcomes, and determinants among adult patients with musculoskeletal infections admitted to Jimma Medical Center: A prospective observational study. PLoS ONE, 2025.
• Enterobacter species Obtained from Poultry Droppings of Selected Farms in Southwest Nigeria is a Hotspot of Antibiotic-Resistant Genes. Asia-Pacific Journal of Science and Technology, 2026.
• Antimicrobial resistance profiles of Escherichia coli derived from an integrated agroforestry-livestock system in Deli Serdang Regency, Indonesia. Veterinary World, 2024.
• Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report. Jmir Public Health and Surveillance, 2020.
• An accelerated method for the detection of extended-spectrum beta-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae.. Saudi Journal of Kidney Diseases and Transplantation an Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia, 2006.
• Physicochemical and microbicidal characteristics of α-Fe2O3 (hematite) nanoparticles immobilized on the dendritic platform of hyperbranched polyglycerol. Chemical Papers, 2024.
• Resistance of bacteria isolated from equipment in an intensive care unit. Acta Paulista De Enfermagem, 2015.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.